Sage Therapeutics Inc. (SAGE)
7.33
-0.11 (-1.48%)
At close: Jan 15, 2025, 11:21 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | 86.45M | 7.69M | 6.31M | 1.11B | 6.87M | 90.27M | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 2.16M | 813.00K | 553.00K | 565.00K | 400.00K | 1.10M | 500.00K | 281.00K | 115.00K | n/a | n/a | n/a |
| Gross Profit | 84.30M | 6.87M | 5.75M | 1.11B | 6.47M | 89.17M | -500.00K | -281.00K | -115.00K | n/a | n/a | n/a |
| Operating Income | -579.85M | -546.99M | -460.91M | 596.23M | -708.12M | -393.24M | -273.15M | -160.16M | -94.65M | -33.81M | -18.28M | -9.63M |
| Interest Income | 38.74M | 14.19M | 2.88M | 9.60M | 27.80M | 20.33M | 3.10M | 1.21M | 178.00K | 8.00K | 1K | n/a |
| Pretax Income | -541.49M | -532.78M | -457.89M | 606.07M | -680.24M | -372.88M | -270.12M | -158.99M | -94.50M | -33.81M | -18.28M | -9.63M |
| Net Income | -541.49M | -503.27M | -450.83M | 606.07M | -650.15M | -372.88M | -270.12M | -158.99M | -94.50M | -33.81M | -18.28M | -9.63M |
| Selling & General & Admin | 274.52M | 227.70M | 183.50M | 196.95M | 345.78M | 201.40M | 62.88M | 39.41M | 25.29M | 9.71M | 3.38M | 2.40M |
| Research & Development | 356.24M | 326.16M | 283.17M | 292.71M | 368.81M | 282.11M | 210.28M | 120.76M | 69.36M | 24.10M | 14.36M | 7.23M |
| Other Expenses | 33.39M | 15.00K | 134.00K | 250.00K | 82.00K | 22.00K | -64.00K | -35.00K | -23.00K | -9.00K | -3.00K | -1K |
| Operating Expenses | 630.76M | 553.86M | 466.66M | 489.67M | 714.59M | 483.51M | 273.15M | 160.16M | 94.65M | 33.81M | 18.28M | 9.63M |
| Interest Expense | n/a | 14.19M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.00K | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | 44.60M | 11.18M | 5.27M | 3.08M | n/a | n/a | n/a |
| Cost & Expenses | 666.69M | 554.67M | 467.22M | 490.23M | 714.99M | 483.51M | 273.15M | 160.16M | 94.65M | 33.81M | 18.28M | 9.63M |
| Income Tax | n/a | -29.52M | -7.07M | 15.52M | -30.09M | 20.36M | -3.63M | -1.49M | -293.00K | -59.00K | 2.00K | n/a |
| Shares Outstanding (Basic) | 59.84M | 59.31M | 58.67M | 51.98M | 50.83M | 46.12M | 38.10M | 33.47M | 27.78M | 21.57M | 16.77M | 16.77M |
| Shares Outstanding (Diluted) | 59.84M | 59.31M | 58.67M | 53.00M | 50.83M | 46.12M | 38.11M | 33.49M | 27.78M | 21.57M | 24.96M | 24.96M |
| EPS (Basic) | -9.05 | -8.49 | -7.68 | 11.66 | -12.79 | -8.08 | -7.09 | -4.75 | -3.4 | -1.57 | -1.09 | -0.57 |
| EPS (Diluted) | -9.05 | -8.49 | -7.68 | 11.43 | -12.79 | -8.08 | -7.09 | -4.75 | -3.4 | -1.57 | -0.73 | -0.39 |
| EBITDA | -545.07M | -545.87M | -456.73M | 626.60M | -705.84M | -392.10M | -269.62M | -160.16M | -94.65M | -33.81M | -18.23M | -9.59M |
| Depreciation & Amortization | 1.39M | 1.12M | 4.18M | 2.63M | 2.28M | 1.10M | 500.00K | 281.00K | 115.00K | 51.00K | 47.00K | 44.00K |